Abstract:Abnormal expression of the cell cycle inhibitor and p53 target CDKN1A /p21 has been associated with paradoxical outcomes, such as hyperproliferation in p53-deficient cancer cells or hypoproliferation that affects hematopoietic stem cell behavior, leading to bone marrow failure (BMF). Notably, p21 is known to be overexpressed in Fanconi anemia (FA), which is a rare syndrome that predisposes patients to BMF and cancer. However, why p21 is overexpressed in FA and how it contributes to the FA phenotype(s) are still poorly understood. Here, we revealed that while the upregulation of p21 is largely dependent on p53, it also depends on the transcription factor microphthalmia (MITF) as well as on its interaction with the nucleolar protein NPM1. Upregulation of p21 expression in FA cells leads to p21 accumulation in the chromatin fraction, p21 immunoprecipitation with PCNA, S-phase lengthening and genetic instability. p21 depletion in FA cells rescues the S-phase abnormalities and reduces their genetic instability. In addition, we observed that reactive oxygen species (ROS) accumulation, another key feature of FA cells, is required to trigger an increase in PCNA/chromatin-associated p21 and to impact replication progression. Therefore, we propose a mechanism by which p21 and ROS cooperate to induce replication abnormalities that fuel genetic instability. Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure and a predisposition to cancer caused by biallelic mutations in genes encoding proteins involved in the FANC/BRCA DNA repair pathway. Bone marrow failure has been attributed to the abnormal overexpression of the p53/p21 axis in response to the inherent DNA damage accompanying the loss of the FANC/BRCA pathway, leading to cell cycle arrest and subsequent hematopoietic stem cell exhaustion. Here, we revealed an alternative pathway that contributes to p21 overexpression independent of p53. Indeed, we found that in TP53 -null cells, the loss of the FANC pathway still leads to p21 overexpression. We demonstrated that this overexpression is dependent on the transcription factor MITF, which increases CDKN1A mRNA (which encodes p21), and on the NPM1 protein, which directly stabilizes p21. Both mechanisms are independent of DNA damage and/or DNA damage signaling, and therefore, this study provides a shift in the paradigm explaining the bone marrow failure observed in Fanconi anemia. Notably, we demonstrated that, in association with the known higher level of ROS in FA cells, the overexpression of p21 contributes to generating replication stress, which contributes to their genetic instability.

Phosphorylation of Fanconi Anemia (FA) Complementation Group G Protein, FANCG, at Serine 7 is Important for Function of the FA Pathway

FANCG is phosphorylated at serines 383 and 387 during mitosis.

Differential Phosphorylation of FANCA and FANCG Determines Response of Fanconi Anemia Core Complex to DNA Damage and S Phase.

Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis

Fanconi Anemia and DNA Interstrand Cross-Link Repair

Fanconi Anemia complementation group C protein in metabolic disorders.

The Fanconi Anemia Core Complex Associates with Chromatin During S Phase.

Functional analysis of Fanconi anemia mutations in China.

Clinical and genetic features of Fanconi anemia associated with a variant of FANCA gene: Case report and literature review

The Emergence of a Unified Mechanism in the Fanconi Anemia Pathway

Fanconi anemia proteins participate in a break-induced-replication-like pathway to counter replication stress

Fan1 Acts with Fanci-Fancd2 to Promote Dna Interstrand Cross-Link Repair

Fanconi anemia with sun-sensitivity caused by a Xeroderma pigmentosum-associated missense mutation in XPF

FANCJ is a Structure-specific DNA Helicase Associated with the Maintenance of Genomic G/C Tracts*

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

The structure of the FANCM–MHF complex reveals physical features for functional assembly

The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation

Novel Variations of FANCA Gene Provokes Fanconi Anemia: Molecular Diagnosis in a Special Chinese Family

Contribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia

FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia

Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy